Brief: Guardant Health Q3 Adjusted EPS USD -0.39 Vs. IBES Estimate USD -0.76
29/10/2025 20:05
Oct 29 (Reuters) - Guardant Health Q3 revenue USD 265.2 million vs. IBES estimate USD 235.7 million. Q3 adjusted net income USD -48.3 million vs. IBES estimate USD -98.5 million Q3 EPS USD -0.74 Q3 adjusted EBITDA USD -45.5 million vs. IBES estimate USD -54.7 million outlook FY revenue USD 965-970 million
Recent news on Guardant Health
See all newsBrief: Guardant Health Announces Approval In Europe Of Guardant360® Cdx
Grail's cancer blood test nears landmark FDA approval, but insurance coverage looms
US Health Secretary Kennedy Jr. adds eight new members to key health committee (updated)
Brief: US FDA Grants Accelerated Approval To Etcamah For Advanced Breast Cancer With ESR1 Mutation
Brief: Guardant Health To Appeal Federal District Court Judgment